These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New TB drug approved. AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361363 [No Abstract] [Full Text] [Related]
4. Good news and not such good news. Iseman MD Int J Tuberc Lung Dis; 1999 Feb; 3(2):87. PubMed ID: 10091871 [No Abstract] [Full Text] [Related]
5. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)]. Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460 [No Abstract] [Full Text] [Related]
6. Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis. Barakat MT; Scott J; Hughes JM; Walport M; Calam J; Friedland JS; Ind PW; McKenna C BMJ; 1996 Dec; 313(7071):1543-5. PubMed ID: 8978236 [No Abstract] [Full Text] [Related]
7. [Myrin P in the combined treatment of tuberculosis]. Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644 [TBL] [Abstract][Full Text] [Related]
8. The impact of chemotherapy on the care of patients with tuberculosis. Johnston RF; Wildrick KH Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115 [No Abstract] [Full Text] [Related]
9. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for tuberculosis today. Stead WW; Dutt AK Am Rev Respir Dis; 1982 Mar; 125(3 Pt 2):94-101. PubMed ID: 7041725 [No Abstract] [Full Text] [Related]
12. [Isolation obligation and therapy in tuberculosis]. Sybrecht GW Dtsch Med Wochenschr; 1997 Oct; 122(41):1265. PubMed ID: 9378057 [No Abstract] [Full Text] [Related]
13. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin]. Sighart H; Opl G; Weirich H Wien Med Wochenschr; 1982 Nov; 132(22):559-61. PubMed ID: 7168180 [No Abstract] [Full Text] [Related]
14. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Schechter M; Zajdenverg R; Falco G; Barnes GL; Faulhaber JC; Coberly JS; Moore RD; Chaisson RE Am J Respir Crit Care Med; 2006 Apr; 173(8):922-6. PubMed ID: 16474028 [TBL] [Abstract][Full Text] [Related]
15. Short-course chemotherapy for pulmonary tuberculosis. Fox W; Mitchison DA Am Rev Respir Dis; 1975 Jun; 111(6):845-8 CONTD. PubMed ID: 49163 [No Abstract] [Full Text] [Related]
16. Recent advances in antituberculosis chemotherapy. Chan SL Xianggang Hu Li Za Zhi; 1979 Nov; (27):19-27. PubMed ID: 317480 [No Abstract] [Full Text] [Related]
17. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection. Stout JE Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147 [TBL] [Abstract][Full Text] [Related]
18. [Short-term treatment of pulmonary tuberculosis]. Karuga WK Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178 [No Abstract] [Full Text] [Related]
19. [Short-course chemotherapy for tuberculosis in Chile. Operational considerations]. Valenzuela P; Valenzuela MT Rev Med Chil; 1984 Mar; 112(3):287-9. PubMed ID: 6473970 [No Abstract] [Full Text] [Related]
20. Chemotherapy of tuberculosis for patients with renal impairment. Ellard GA Nephron; 1993; 64(2):169-81. PubMed ID: 8321347 [No Abstract] [Full Text] [Related] [Next] [New Search]